retatrutide clinical trials review Weight Loss Treatment Explained Retatrutide clinical trial done! Now

This revolutionary ultrasound therapy specifically targets skin laxity on the upper arms, abdomen, buttocks, thighs, and knees with a quick, comfortable treatment requiring zero downtime

The SURPASS program established efficacy in type 2 diabetes across multiple comparators, including head-to-head superiority versus semaglutide on HbA1c reduction in SURPASS-2 (Fras et al., NEJM, 2021)

Going in with a realistic understanding of what the evidence shows - including the weight regain data - helps you make a more informed enrollment decision and set more accurate expectations for the program's timeline

Current Regulatory Status in the UK Retatrutide is not approved by the MHRA or EMA and is unavailable as a licensed medicine in the UK